Integrated Diagnostics Holdings plc (IDGXF)
OTCMKTS
· Delayed Price · Currency is USD
0.3200
0.00 (0.00%)
At close: May 12, 2025
IDGXF Revenue
In the year 2024, Integrated Diagnostics Holdings had annual revenue of 5.72B EGP with 38.74% growth. Integrated Diagnostics Holdings had revenue of 1.61B in the quarter ending December 31, 2024, with 50.72% growth.
Revenue
5.72B EGP
Revenue Growth
+38.74%
P/S Ratio
1.86
Revenue / Employee
906.60K EGP
Employees
6,309
Market Cap
209.28M USD
Revenue Chart
* This company reports financials in EGP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.72B | 1.60B | 38.74% |
Dec 31, 2023 | 4.12B | 517.46M | 14.35% |
Dec 31, 2022 | 3.61B | -1.62B | -31.00% |
Dec 31, 2021 | 5.22B | 2.57B | 96.69% |
Dec 31, 2020 | 2.66B | 429.77M | 19.30% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |